By Michael Susin
Futura Medical said the Mexican Secretariat of Health has granted a marketing authorization for its topical gel formulation for the treatment of erectile dysfunction.
The pharmaceutical company on Wednesday said Eroxon is now authorized to be sold over the counter, meaning it won’t require a medical prescription to be acquired.
“Following the approval by the U.S. FDA earlier this year, Mexican marketing authorization opens up another very large and exciting market for Eroxon,” Chief Executive James Barder said.
Write to Michael Susin at [email protected]
Read the full article here